These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21762326)
1. Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients. Patel M; Stefanidou M; Long CB; Fazzari MJ; Tesfa L; Del Rio M; Lamour J; Ricafort R; Madan RP; Herold BC Pediatr Transplant; 2012 Feb; 16(1):18-28. PubMed ID: 21762326 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients. Lee H; Park KH; Ryu JH; Choi AR; Yu JH; Lim J; Han K; Kim SI; Yang CW; Chung BH; Oh EJ PLoS One; 2017; 12(12):e0189488. PubMed ID: 29232714 [TBL] [Abstract][Full Text] [Related]
3. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients]. Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495 [TBL] [Abstract][Full Text] [Related]
5. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment. Fernández-Ruiz M; Giménez E; Vinuesa V; Ruiz-Merlo T; Parra P; Amat P; Montejo M; Paez-Vega A; Cantisán S; Torre-Cisneros J; Fortún J; Andrés A; San Juan R; López-Medrano F; Navarro D; Aguado JM; Clin Microbiol Infect; 2019 Mar; 25(3):381.e1-381.e10. PubMed ID: 29803844 [TBL] [Abstract][Full Text] [Related]
6. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation. Giménez E; Muñoz-Cobo B; Solano C; Amat P; de la Cámara R; Nieto J; López J; Remigia MJ; Garcia-Noblejas A; Navarro D Transpl Infect Dis; 2015 Jun; 17(3):361-70. PubMed ID: 25850900 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients. Carbone J; Lanio N; Gallego A; Kern F; Navarro J; Muñoz P; Alonso R; Catalán P; Fernández-Yáñez J; Palomo J; Ruiz M; Fernández-Cruz E; Sarmiento E J Clin Immunol; 2012 Aug; 32(4):809-19. PubMed ID: 22371292 [TBL] [Abstract][Full Text] [Related]
8. Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study. Banas B; Steubl D; Renders L; Chittka D; Banas MC; Wekerle T; Koch M; Witzke O; Mühlfeld A; Sommerer C; Habicht A; Hugo C; Hünig T; Lindemann M; Schmidt T; Rascle A; Barabas S; Deml L; Wagner R; Krämer BK; Krüger B Transpl Int; 2018 Apr; 31(4):436-450. PubMed ID: 29284181 [TBL] [Abstract][Full Text] [Related]
9. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982 [TBL] [Abstract][Full Text] [Related]
10. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation. Merindol N; Salem Fourati I; Brito RM; Grenier AJ; Charrier E; Cordeiro P; Caty M; Mezziani S; Malette B; Duval M; Alfieri C; Ovetchkine P; Le Deist F; Soudeyns H J Immunol; 2012 Nov; 189(10):5016-28. PubMed ID: 23034171 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients. Abate D; Saldan A; Mengoli C; Fiscon M; Silvestre C; Fallico L; Peracchi M; Furian L; Cusinato R; Bonfante L; Rossi B; Marchini F; Sgarabotto D; Rigotti P; Palù G J Clin Microbiol; 2013 Aug; 51(8):2501-7. PubMed ID: 23678073 [TBL] [Abstract][Full Text] [Related]
12. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection. Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542 [TBL] [Abstract][Full Text] [Related]
13. Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs. Kaminski H; Jarque M; Halfon M; Taton B; Di Ascia L; Pfirmann P; Visentin J; Garrigue I; Déchanet-Merville J; Moreau JF; Crespo E; Montero N; Melilli E; Meneghini M; Pascual M; Couzi L; Manuel O; Bestard O; Merville P J Infect Dis; 2019 Jul; 220(5):761-771. PubMed ID: 31157865 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients. Abate D; Saldan A; Fiscon M; Cofano S; Paciolla A; Furian L; Ekser B; Biasolo MA; Cusinato R; Mengoli C; Bonfante L; Rossi B; Rigotti P; Sgarabotto D; Barzon L; Palù G J Infect Dis; 2010 Aug; 202(4):585-94. PubMed ID: 20594105 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study. Chanouzas D; Small A; Borrows R; Ball S PLoS One; 2018; 13(3):e0193968. PubMed ID: 29558479 [TBL] [Abstract][Full Text] [Related]
16. Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants. Abate D; Saldan A; Forner G; Tinto D; Bianchin A; Palù G J Virol Methods; 2014 Feb; 196():157-62. PubMed ID: 24216234 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients. Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473 [TBL] [Abstract][Full Text] [Related]
20. A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients. Kumar D; Chin-Hong P; Kayler L; Wojciechowski D; Limaye AP; Osama Gaber A; Ball S; Mehta AK; Cooper M; Blanchard T; MacDougall J; Kotton CN Am J Transplant; 2019 Sep; 19(9):2505-2516. PubMed ID: 30768834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]